Peptonic Medical takes 8.3% stake in DGH International for SEK 12.5M
What's the deal? Peptonic MedicalDealroom has a profile for this one. Try Dealroom →, a Swedish women's intimate health company, has acquired a roughly 8.3% stake in DGH InternationalDealroom has a profile for this one. Try Dealroom → — formerly Intellego TechnologiesDealroom has a profile for this one. Try Dealroom → — for SEK 12.495 million. The deal, closed on 2 September 2026, gives Peptonic 2,776,673 shares in the votes and capital of DGH.
What does DGH do? It develops and commercialises patented UV indicator technology for disinfection and industrial uses. Peptonic points to DGH's subsidiary Daro Group InternationalDealroom has a profile for this one. Try Dealroom → as the key value driver, citing what it calls "good profitability, a strong market position and significant growth potential."
How is it structured? Peptonic is paying SEK 2.4 million in cash, taking SEK 9.0 million in loans from the sellers, and deferring SEK 1.1 million until no later than 31 December 2026. The seller loans run until further notice, and lenders can later request that all or part be set off against newly issued Peptonic shares, subject to board approval.
Why now? Peptonic's growth strategy leans on geographic expansion in the US and Europe alongside "strategic investments." The DGH stake sits alongside its core VagiVitalDealroom has a profile for this one. Try Dealroom → and VerniviaDealroom has a profile for this one. Try Dealroom → self-care brands as a bet outside its primary market.
What could go wrong? Peptonic's board flagged risks in DGH, including ongoing disputes and potential claims against the company. It concluded the investment still offers "attractive risk-adjusted potential" based on estimated values in DGH's operations, technology, IP, and patent portfolio.
The signal: A small women's health medtech taking a minority position in an unrelated UV-technology group signals a shift toward opportunistic, capital-light dealmaking — funded largely by seller loans convertible into equity rather than upfront cash.
Read more: news.cision.com
Image credit: Generated with Gemini
